Literature DB >> 2743607

Regional norepinephrine turnover in human hypertension.

M Esler1, G Lambert, G Jennings.   

Abstract

Overall and regional rates of norepinephrine overflow to plasma were measured in 55 untreated patients with primary hypertension and in 40 healthy subjects, to study sympathetic nervous pathophysiology in human hypertension. Total norepinephrine spillover was increased in primary hypertension, particularly in patients aged less than 40 years, largely due to higher rates of renal and cardiac norepinephrine overflow. Renal renin release, and arterial plasma renin activity, were highest in these younger patients with increased renal sympathetic nervous activity. In older patients sympathetic activity and norepinephrine release was typically normal. A selective increase in the sympathetic nervous outflow to the heart and kidneys is commonly present in young patients with primary hypertension, and probably contributes materially to the early pathogenesis of the hypertension.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2743607     DOI: 10.3109/10641968909045414

Source DB:  PubMed          Journal:  Clin Exp Hypertens A        ISSN: 0730-0077


  26 in total

Review 1.  Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options.

Authors:  Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 2.  Renal denervation: effects on atrial electrophysiology and arrhythmias.

Authors:  Dominik Linz; Arne van Hunnik; Christian Ukena; Sebastian Ewen; Felix Mahfoud; Stephan H Schirmer; Matthias Lenski; Hans-Ruprecht Neuberger; Ulrich Schotten; Michael Böhm
Journal:  Clin Res Cardiol       Date:  2014-03-29       Impact factor: 5.460

Review 3.  Renal sympathetic denervation: applications in hypertension and beyond.

Authors:  Michael Böhm; Dominik Linz; Daniel Urban; Felix Mahfoud; Christian Ukena
Journal:  Nat Rev Cardiol       Date:  2013-06-18       Impact factor: 32.419

4.  Altered regulation of the rostral ventrolateral medulla in hypertensive obese Zucker rats.

Authors:  Domitila A Huber; Ann M Schreihofer
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-05-02       Impact factor: 4.733

5.  Renal Sympathetic Denervation for Treatment of Hypertension.

Authors:  Eduardo Pimenta; Suzanne Oparil
Journal:  Curr Treat Options Cardiovasc Med       Date:  2012-02-01

Review 6.  Role of the sympathetic nervous system in hypertension and hypertension-related cardiovascular disease.

Authors:  Gino Seravalle; Giuseppe Mancia; Guido Grassi
Journal:  High Blood Press Cardiovasc Prev       Date:  2014-05-01

Review 7.  The Role of Central Nervous System Mechanisms in Resistant Hypertension.

Authors:  Dagmara Hering; Markus Schlaich
Journal:  Curr Hypertens Rep       Date:  2015-08       Impact factor: 5.369

Review 8.  Neurogenic hypertension: pathophysiology, diagnosis and management.

Authors:  Samuel J Mann
Journal:  Clin Auton Res       Date:  2018-07-04       Impact factor: 4.435

Review 9.  The sympathetic nervous system alterations in human hypertension.

Authors:  Guido Grassi; Allyn Mark; Murray Esler
Journal:  Circ Res       Date:  2015-03-13       Impact factor: 17.367

Review 10.  Renal denervation: a novel non-pharmacological approach in heart failure.

Authors:  Michael Böhm; Sebastian Ewen; Dominik Linz; Jan-C Reil; Stephan Schirmer; Christian Ukena; Felix Mahfoud
Journal:  J Cardiovasc Transl Res       Date:  2014-02-28       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.